CODMAN BICOL SPONGE 80-1460

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 1998-06-22 for CODMAN BICOL SPONGE 80-1460 manufactured by Johnson & Johnson Professional, Inc..

Event Text Entries

[95423] A bicol collagen sponge was utilized during a recent craniotomy. When the bicol sponge removal was attempted, great difficulty was encountered. According to the surgeon, the bicol sponge appeared to be in good condition upon application, and that all appeared normal during use. When removal was attempted the bicol sponge tore into many pieces and adhered to the adjacent tissue. This adherence caused significant trauma when removed.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219655-1998-00113
MDR Report Key173290
Report Source06
Date Received1998-06-22
Date of Report1998-06-22
Date Mfgr Received1998-05-25
Device Manufacturer Date1997-04-01
Date Added to Maude1998-06-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameCODMAN BICOL SPONGE
Generic NameSURGICAL SPONGE
Product CodeGER
Date Received1998-06-22
Model NumberNA
Catalog Number80-1460
Lot NumberDP285
ID NumberNI
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedU
Device Sequence No1
Device Event Key168485
ManufacturerJOHNSON & JOHNSON PROFESSIONAL, INC.
Manufacturer Address325 PARAMOUNT DR RAYNHAM MA 027670350 US
Baseline Brand NameCODMAN BICOL SPONGE
Baseline Generic NameSURGICAL SPONGE
Baseline Model NoNA
Baseline Catalog No80-1460
Baseline IDNA
Baseline Device FamilyBICOL SPONGE
Baseline Shelf Life [Months]NA
Baseline PMA FlagN
Baseline 510K PMNN
Baseline PreamendmentY
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 1998-06-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.